Trial intelligence / Profile preview

MSCs for Renal Transplant Tolerance (MSC-KTX)

NCT00752479Phase 2Terminated

Sponsor
Mario Negri Institute for Pharmacological Research
Start
May 2008
Primary completion
Jul 2013
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of mesenchymal stem cells in kidney transplantation, sponsored by Mario Negri Institute for Pharmacological Research. Started May 2008; status: terminated.

02

Drugs

mesenchymal stem cells
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT00752479.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00752479.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call